News & Articles

First at-home, virtually guided service to bring rapid, reliable and affordable testing into the home where the result is delivered in minutes

The EnSite X EP System is a new cardiac mapping system designed from electrophysiologist input to optimize cardiac ablation procedures

Availability of the new IgM blood test on the ARCHITECT and Alinity platforms is part of Abbott's effort to offer tests across the disease progression of COVID-19

With the smallest and thinnest wearable glucose sensor, FreeStyle Libre 3 users may view their glucose levels discreetly and conveniently, anytime

CE mark for MitraClip G4 offers physicians an innovative next-generation system with more options for mitral valve repair using proven clip-based technology

Abbott is collaborating with sports performance technology company Supersapiens to advance this first-of-its-kind product

Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5%

Trial supports Abbott's focus on being the best partner for electrophysiologists treating people living with atrial fibrillation

The NeuroSphere Digital Care offers flexible virtual care options as the COVID-19 global pandemic impacts how healthcare is administered

Gallant ICD and CRT-D devices feature a patient-preferred design without compromising on battery longevity and compatibility with magnetic resonance imaging (MRI)

Companies partner to integrate Abbott's FreeStyle Libre continuous glucose monitoring technology with Tandem's insulin delivery products to provide options to simplify and tailor diabetes management

Additional real-world data demonstrate meaningful outcomes for people living with diabetes who use Abbott's glucose sensing technology

Test will be available at NHS laboratories across the UK, using its ARCHITECT i1000SR and i2000SR and Alinity i laboratory instruments

Interim clinical study data shows ID NOW test performance of 94.7% sensitivity and 98.6% specificity

The company says it continues to optimize its coronavirus test amid questions about its accuracy

The Alinity m molecular laboratory COVID-19 test instrument claims it can run up to 1,080 tests in 24 hours

The test will be available for qualified laboratories across the European Union by the end of May

The FreeStyle Libre 14 day system can be used by frontline healthcare workers tackling the coronavirus

The Abbott ID NOW™ COVID-19 test aims to bring rapid testing to the front lines of the global pandemic

The test will be used on the m2000 RealTime system that is currently available in hospitals and molecular laboratories in the U.S.

New Gallant high-voltage devices offer patients and their doctors a smartphone app and Bluetooth connectivity

Tendyne valve provides relief from heart failure symptoms and quality-of-life improvement in high-surgical-risk patients

Abbott is making this new strain accessible to the research community to evaluate its impact on diagnostics, treatment and potential vaccines